Farshid Siadat

499 total citations
15 papers, 175 citations indexed

About

Farshid Siadat is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Farshid Siadat has authored 15 papers receiving a total of 175 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 7 papers in Molecular Biology and 6 papers in Physiology. Recurrent topics in Farshid Siadat's work include Renal cell carcinoma treatment (7 papers), Tuberous Sclerosis Complex Research (6 papers) and Renal and related cancers (6 papers). Farshid Siadat is often cited by papers focused on Renal cell carcinoma treatment (7 papers), Tuberous Sclerosis Complex Research (6 papers) and Renal and related cancers (6 papers). Farshid Siadat collaborates with scholars based in Canada, United States and Germany. Farshid Siadat's co-authors include Kiril Trpkov, Reza Alaghehbandan, Theodorus van der Kwast, Najla Aldaoud, Jenna Sykes, Rodolfo Montironi, Alexandre R. Zlotta, Robert G. Bristow, Cynthia Kuk and Shin Egawa and has published in prestigious journals such as Modern Pathology, Cancers and Laboratory Investigation.

In The Last Decade

Farshid Siadat

13 papers receiving 175 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Farshid Siadat Canada	6	154	91	44	29	22	15	175
Tyler Kolisnik Canada	5	100 0.6×	61 0.7×	59 1.3×	11 0.4×	22 1.0×	10	173
Mahmut Akgül United States	7	115 0.7×	76 0.8×	31 0.7×	60 2.1×	25 1.1×	50	181
Jindong Dai China	9	117 0.8×	58 0.6×	55 1.3×	29 1.0×	5 0.2×	35	191
Ines deTorres Spain	3	170 1.1×	155 1.7×	29 0.7×	56 1.9×	10 0.5×	6	187
Mark Bi United States	4	103 0.7×	62 0.7×	53 1.2×	44 1.5×	7 0.3×	5	166
Judi C. Herring United States	4	149 1.0×	132 1.5×	46 1.0×	29 1.0×	20 0.9×	6	183
Hannah Bye United Kingdom	8	53 0.3×	76 0.8×	35 0.8×	43 1.5×	6 0.3×	14	163
Songliang Du China	8	123 0.8×	108 1.2×	48 1.1×	44 1.5×	4 0.2×	18	169
Xiuyi Pan China	6	90 0.6×	68 0.7×	38 0.9×	14 0.5×	6 0.3×	17	132
Ricardo Pereira Mestre Switzerland	8	150 1.0×	36 0.4×	48 1.1×	13 0.4×	8 0.4×	22	214

Countries citing papers authored by Farshid Siadat

Since Specialization

Citations

This map shows the geographic impact of Farshid Siadat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farshid Siadat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farshid Siadat more than expected).

Fields of papers citing papers by Farshid Siadat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farshid Siadat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farshid Siadat. The network helps show where Farshid Siadat may publish in the future.

Co-authorship network of co-authors of Farshid Siadat

This figure shows the co-authorship network connecting the top 25 collaborators of Farshid Siadat. A scholar is included among the top collaborators of Farshid Siadat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farshid Siadat. Farshid Siadat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Trpkov, Kiril, Inmaculada Ribera‐Cortada, Isabel Trias, et al.. (2025). Renal hemangioblastoma and renal cell carcinoma with fibromyomatous stroma and hemangioblastoma-like areas belong to the spectrum of one entity. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 1 indexed citations

Trpkov, Kiril, Farshid Siadat, & Rola Saleeb. (2025). Recent developments in eosinophilic renal neoplasms: what's new, true and important?. Histopathology. 88(1). 166–192.

Pautler, Stephen E., Haiying Chen, Madeleine Moussa, et al.. (2025). 766 Renal Cell Carcinoma with Fibromyomatous Stroma (RCC FMS) with Hemangioblastoma (HB)-like Areas is Part of the Morphologic Spectrum of RCC FMS in Patients with Tuberous Sclerosis Complex. Laboratory Investigation. 105(3). 102999–102999. 2 indexed citations

House, Andrew A., Stephen E. Pautler, Haiying Chen, et al.. (2025). Renal cell carcinoma with fibromyomatous stroma (RCC FMS) and with hemangioblastoma‐like areas is part of the RCC FMS spectrum in patients with tuberous sclerosis complex. Histopathology. 87(5). 687–699. 1 indexed citations

Alaghehbandan, Reza, Farshid Siadat, & Kiril Trpkov. (2023). What’s new in the WHO 2022 classification of kidney tumours?. Pathologica. 115(1). 1–15. 31 indexed citations

Siadat, Farshid, et al.. (2023). Kidney Tumors. Clinics in Laboratory Medicine. 43(2). 275–298.

Zhou, Ming, et al.. (2022). Should grade group 1 prostate cancer be reclassified as “non-cancer”? A pathology community perspective. Urologic Oncology Seminars and Original Investigations. 41(2). 62–64. 2 indexed citations

Siadat, Farshid, et al.. (2022). Kidney Tumors. Surgical pathology clinics. 15(4). 713–728. 3 indexed citations

Sangoi, Ankur R., Emily Chan, Eman Abdulfatah, et al.. (2022). p53 null phenotype is a “positive result” in urothelial carcinoma in situ. Modern Pathology. 35(9). 1287–1292. 5 indexed citations

10.

Siadat, Farshid, et al.. (2022). Low-grade oncocytic tumor (LOT) - a new renal entity ready for a prime time: An updated review.. PubMed. 37(5). 405–413. 8 indexed citations

11.

Ren, Bing, Geoffrey Gotto, Summit Sawhney, et al.. (2022). Extrarenal renal cell carcinoma arising in the kidney proximity but without an identifiable renal primary – an intriguing dilemma: report of three cases and review of the literature. Histopathology. 81(5). 635–643. 7 indexed citations

12.

Siadat, Farshid & Kiril Trpkov. (2020). ESC, ALK, HOT and LOT: Three Letter Acronyms of Emerging Renal Entities Knocking on the Door of the WHO Classification. Cancers. 12(1). 168–168. 56 indexed citations

13.

Siadat, Farshid. (2018). Cribriform morphology in prostate pathology. Diagnostic histopathology. 24(6). 215–219. 1 indexed citations

14.

Olkhov‐Mitsel, Ekaterina, Farshid Siadat, Ken J. Kron, et al.. (2017). Distinct DNA methylation alterations are associated with cribriform architecture and intraductal carcinoma in Gleason pattern 4 prostate tumors. Oncology Letters. 14(1). 390–396. 17 indexed citations

15.

Siadat, Farshid, Jenna Sykes, Alexandre R. Zlotta, et al.. (2015). Not all gleason pattern 4 prostate cancers are created equal: A study of latent prostatic carcinomas in a cystoprostatectomy and autopsy series. The Prostate. 75(12). 1277–1284. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact